|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 14/55 | (2006.01) |
| A61K 38/20 | (2006.01) | ||
| C07K 16/00 | (2006.01) |
| (11) | Number of the document | 2970441 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14769541.5 |
| Date of filing the European patent application | 2014-03-14 | |
| (97) | Date of publication of the European application | 2016-01-20 |
| (45) | Date of publication and mention of the grant of the patent | 2019-03-06 |
| (46) | Date of publication of the claims translation | 2019-06-10 |
| (86) | Number | PCT/US2014/028913 |
| Date | 2014-03-14 |
| (87) | Number | WO 2014/153063 |
| Date | 2014-09-25 |
| (30) | Number | Date | Country code |
| 201361784669 P | 2013-03-14 | US |
| (72) |
KANNAN, Gunasekaran, US
|
| (73) |
Amgen Inc.,
One Amgen Center Drive, Thousand Oaks, California 91320-1799,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Aglikozilinti Fc turintys polipeptidai |
| AGLYCOSYLATED Fc-CONTAINING POLYPEPTIDES |
| Payment date | Validity (years) | Amount | |
| 2026-02-19 | 13 | 289.00 EUR |
| 2027-03-14 |